drug · antibody drug conjugate
patient view →cetuximab sarotalocan
Phase 3updated 2mo agoby Rakuten Medical Inc🔗 ChEMBL
Phase 3community read0 votes
Antibody drug conjugate drug with a maximum clinical stage of Approval (across all indications), with an approval for head and neck malignant neoplasia and 1 investigational indication.
targets
Epidermal growth factor receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that